mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
AZD-2281 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
SCH-529074 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
TGX221 |
GDSC1000 |
pan-cancer |
AAC |
-0.024 |
0.6 |
mRNA |
NSC-207895 |
GDSC1000 |
pan-cancer |
AAC |
-0.017 |
0.6 |
mRNA |
BMS-195614 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
AZD8055 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
Ko-143 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |